drugset / Trial / NCT04709601

Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in Women With Recurring Urinary Tract Infections.

NCT04709601 ↗

Phase 4 Terminated 14 enrolled University of Texas Southwestern Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to measure the concentration of formaldehyde in the urine of women with recurrent urinary tract infections on Hiprex; and then, assuming its urinary presence is confirmed at the proper acid urinary pH, evaluate if such a therapy has favorable effects in decreasing the rate of recurrent urinary tract infections over time.

Timeline

Start
2021-01-04
Primary completion
2024-12-31
Completion
2024-12-31

Outcome

Outcome not reported

Stopped: “Because the study investigator is no longer following these patients as part of this study. They are followed as part of SOC as the study investigator's patients.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Methenamine Hippurate Unknown 1 g Oral